Clinical Trials Browser

Phase 3 × OTHER × Gynecologic × Clear all

NCT05581121 2026-04-14

PAROLA

Phase 3 Recruiting

Adenocarcinoma, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT04878094 2026-04-09

A Study of Intra-operative Imaging in Women With Ovarian Cancer

Phase 3 Recruiting

Ovarian Neoplasms

NCT03772028 2026-04-08

OVHIPEC-2

Phase 3 Active not recruiting

Ovarian Neoplasms

NCT01226394 2026-04-06

ProphyloCHIP

Phase 3 Completed

Krukenberg Tumor, Peritoneal Neoplasms

NCT06915727 2026-04-01

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Phase 3 Recruiting

GynecologicHead & Neck

Head and Neck Neoplasms, Pelvic Neoplasms

NCT03979014 2026-03-31

NOVEL

Phase 3 Completed

Uterine Cervical Neoplasms, Neoplasms

NCT04095364 2026-03-24

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 3 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06580314 2026-03-24

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Phase 3 Recruiting

Ovarian Neoplasms

NCT04789694 2026-03-19

PHOCUS

Phase 3 Recruiting

Frailty, Ovarian Neoplasms, Endometrial Neoplasms

NCT03842982 2026-03-16

CHIPPI

Phase 3 Active not recruiting

Ovarian Neoplasms

NCT04575935 2026-03-05

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Phase 3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06651697 2026-02-17

BEFORE

Phase 3 Recruiting

Pelvic Neoplasms

NCT07400536 2026-02-10

A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT

Phase 3 Not yet recruiting

Locally Advanced Cervical Carcinoma

NCT07286162 2026-01-27

CALM-TF

Phase 3 Not yet recruiting

Ovarian Neoplasms, Recurrence

NCT06712472 2026-01-20

RAINBO-RED

Phase 3 Recruiting

Endometrial Neoplasms

NCT06963268 2025-12-19

SENTOV II

Phase 3 Recruiting

Ovarian Neoplasms

NCT03422198 2025-12-12

SAVE

Phase 3 Recruiting

188 enrolled 15 charts

GynecologicSarcoma

Endometrial Clear Cell Adenocarcinoma

NCT04157985 2025-12-11

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

Phase 3 Completed

DermatologicGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Cholangiocarcinoma

NCT06476184 2025-12-05

SALVOVAR

Phase 3 Recruiting

Ovarian Neoplasms

NCT05201547 2025-12-04

DOMENICA

Phase 3 Active not recruiting

Neoplasm Metastasis, Endometrial Neoplasms

NCT06007586 2025-12-04

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

Phase 3 Completed

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vomiting, Endometrial Neoplasms

NCT04537156 2025-11-21

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Phase 3 Active not recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Condylomata Acuminata

NCT01223248 2025-11-04

Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy

Phase 3 Active not recruiting

DermatologicGynecologicSarcoma

Melanoma, Ovarian Neoplasms, Sarcoma, Pyloric Stenosis, Hypertrophic

NCT06817161 2025-10-07

ESTANVO

Phase 3 Recruiting

Digestive System Diseases, Ovarian Neoplasms

NCT02834637 2025-09-10

DoRIS

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT05009082 2025-09-10

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

Phase 3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04534075 2025-09-08

FIDURA

Phase 3 Completed

GastrointestinalGenitourinaryGynecologic

Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Flatulence, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

NCT06839092 2025-07-30

PROPAC

Phase 3 Not yet recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT05056402 2025-07-22

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Phase 3 Active not recruiting

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT03348150 2025-07-17

PERISCOPEII

Phase 3 Active not recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT05796973 2025-06-27

MOVES

Phase 3 Recruiting

BreastGenitourinaryGynecologic

Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT06954584 2025-06-24

Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer

Phase 3 Recruiting

Ovarian Neoplasms

NCT04503668 2025-06-18

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Phase 3 Terminated

62 enrolled 16 charts

Gynecologic Cancer

NCT05078047 2025-06-05

MOIO

Phase 3 Recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & Neck

Esophageal Squamous Cell Carcinoma, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06990503 2025-05-25

SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer

Phase 3 Not yet recruiting

Ovarian Neoplasms

NCT06980545 2025-05-20

Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer

Phase 3 Not yet recruiting

Stage III and IV Ovarian Cancer

NCT03603184 2025-05-09

AtTEnd

Phase 3 Completed

Neoplasms, Endometrial Neoplasms

NCT05763667 2025-04-24

Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer

Phase 3 Completed

Endometrial Hyperplasia, Pain, Postoperative, Endometrial Neoplasms

NCT01376752 2025-04-23

CHIPOR

Phase 3 Active not recruiting

Ovarian Epithelial Cancer Recurrent

NCT06641635 2025-03-18

Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT06870565 2025-03-17

Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma

Phase 3 Not yet recruiting

Uterine Cervical Neoplasms

NCT04421547 2025-03-07

MITO32

Phase 3 Terminated

Carcinoma, Ovarian Epithelial

NCT02891824 2025-02-11

ATALANTE

Phase 3 Completed

Ovarian Neoplasms

NCT05737303 2025-02-11

Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer

Phase 3 Recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT04508309 2025-01-30

Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls

Phase 3 Completed

1,025 enrolled 32 charts

Uterine Cervical Neoplasms

NCT05601700 2025-01-27

LEPRE

Phase 3 Recruiting

Carcinoma, Ovarian Epithelial

NCT03556839 2025-01-08

BEATcc

Phase 3 Active not recruiting

Carcinoma, Uterine Cervical Neoplasms

NCT06732635 2024-12-13

FAST-TRACK

Phase 3 Completed

Endometrial Neoplasms

NCT01566240 2024-12-05

INTERLACE

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT04227522 2024-11-15

MAMOC

Phase 3 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Adenocarcinoma, Clear Cell